October 2017

Researchers prove the effectiveness of a new drug to prevent the onset and the pain of chemotherapy-induced neuropathy

Leave a Comment / Neuro-Oncology / By

Peripheral neuropathy is a very common side-effect of chemotherapy and may eventually lead to early discontinuation of treatment. Collaboration between research and industry led to the identification and successful testing of a new molecule capable of preventing this neurological complication. This molecule could potentially become the first existing treatment to prevent this frequent adverse effect and improve the quality of life of cancer patients. Article citation

Researchers prove the effectiveness of a new drug to prevent the onset and the pain of chemotherapy-induced neuropathy Read More »

A new genetic marker accounts for up to 1.4% of cases of hereditary colon cancer

Leave a Comment / Uncategorised / By

Researchers from the Hereditary Cancer group of the Oncobell Program of the Bellvitge Biomedical Research Institute (IDIBELL) – Hereditary Cancer Program of the Catalan Institute of Oncology (ICO) have found a new genetic marker that would explain up to 1.4% of those inherited colon cancer cases not related to the mutations currently associated with this

A new genetic marker accounts for up to 1.4% of cases of hereditary colon cancer Read More »

Scroll to Top